Assessment of the Pharmacogenomics Educational Environment in Southeast Europe

被引:32
作者
Pisanu, Claudia [1 ]
Tsermpini, Evangelia-Eirini [2 ]
Mavroidi, Eirini [2 ]
Katsila, Theodora [2 ]
Patrinos, George P. [2 ]
Squassina, Alessio [1 ]
机构
[1] Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, Sch Med, IT-09042 Cagliari, Italy
[2] Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece
关键词
Genetics education; Healthcare professionals; Pharmacogenomics/pharmacogenetics; Southeast Europe; University curricula; PERSONALIZED MEDICINE; PHYSICIANS; GREECE;
D O I
10.1159/000366461
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background/Aims: Pharmacogenomics aims to use the information derived from an individual's genomic profile in the context of individualizing medical treatment modalities. However, currently, pharmacogenomics education is not uniformly provided to health care professionals. This study investigates the status of pharmacogenomics education in Southeast Europe. Methods: University websites served as information sources in order to investigate the discrepancies in pharmacogenomics education in Southeast Europe. In parallel, a survey was conducted at the University of Cagliari (Italy) to test pharmacogenomics knowledge and understanding among specialists, residents and undergraduate students. Results: Our study shows that pharmacogenomics knowledge is not uniformly spread in universities in Southeast Europe and provides the basis for the harmonization of pharmacogenomics education that would directly impact on a smoother integration of pharmacogenomics into mainstream medical practice. Also, a considerable gap in pharmacogenomics education was obvious between the group of specialists and the groups of residents and undergraduate students. Conclusions: Pharmacogenomics education as well as the continuous enrichment of pharmacogenomics knowledge for health care professionals are fundamental approaches toward personalized medicine. Ideally, pharmacogenomics should be taught as a stand-alone course or at least in the context of genetics courses that already exist in universities in Southeast Europe. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:272 / 279
页数:8
相关论文
共 12 条
[1]   Education: Teaching pharmacogenornics to prepare future physicians and researchers for personalized medicine [J].
Gurwitz, D ;
Weizman, A ;
Rehavi, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (03) :122-125
[2]   Primary care physicians' knowledge of and experience with pharmacogenetic testing [J].
Haga, S. B. ;
Burke, W. ;
Ginsburg, G. S. ;
Mills, R. ;
Agans, R. .
CLINICAL GENETICS, 2012, 82 (04) :388-394
[3]   Survey of genetic counselors and clinical geneticists' use and attitudes toward pharmacogenetic testing [J].
Haga, S. B. ;
O'Daniel, J. M. ;
Tindall, G. M. ;
Mills, R. ;
Lipkus, I. M. ;
Agans, R. .
CLINICAL GENETICS, 2012, 82 (02) :115-120
[4]   Key challenges for next-generation pharmacogenomics [J].
Kampourakis, Kostas ;
Vayena, Effy ;
Mitropoulou, Christina ;
van Schaik, Ron H. ;
Cooper, David N. ;
Borg, Joseph ;
Patrinos, George P. .
EMBO REPORTS, 2014, 15 (05) :472-476
[5]  
Mai Y, 2014, PERS MED, V11, P15, DOI [10.2217/PME.13.92, 10.2217/pme.13.92]
[6]  
Mai Y, 2011, PERS MED, V8, P551, DOI [10.2217/PME.11.48, 10.2217/pme.11.48]
[7]  
Mette L, 2012, PHARMACOGENOMICS, V13, P803, DOI [10.2217/PGS.12.52, 10.2217/pgs.12.52]
[8]  
Patrinos George P, 2010, Hum Genomics, V4, P371
[9]  
Reydon TAC, 2012, PERS MED, V9, P633, DOI [10.2217/PME.12.69, 10.2217/pme.12.69]
[10]  
Squassina Alessio, 2012, Pharmacogenomics, V13, P525, DOI 10.2217/pgs.12.22